Edgewise Therapeutics develops small molecule medicines for rare muscle diseases, based in Boulder, Colorado. It last closed at $39.91 on Nov 20, down 3.07% on the day. The next earnings report for EWTX is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, EWTX reported EPS of $9.65. Over its last 8 reports the stock moved an average of 2.5% the session after earnings. Over the last 12 months EWTX insiders bought $0 of stock on the open market and sold $17.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is EWTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold EWTX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on EWTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
EWTX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 5% below its 20 day and 3% below its 50 day average. It is 6% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 44). The nearest support is the Pivot S1 at $39.27, and the nearest resistance the Pivot at $40.34.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 6.6%/day
Key levels
$48.7852 week high+22.2%
$41.8520 day average+4.9%
$41.81100 day average+4.8%
$41.1450 day average+3.1%
$40.97Pivot R1+2.7%
$40.77Swing high (Jun 1)+2.2%
$40.34Pivot+1.1%
$39.91Last close
$39.27Pivot S1−1.6%
$38.51Swing low (Sep 29)−3.5%
$37.34200 day average−6.4%
$19.7652 week low−50.5%
Indicators
RSI (14)
44.19
Middle of its range
Neutral
MACD
0.52
Below its signal line
Bearish
Stochastic
34.1
Middle of its range
Neutral
ADX (14)
18.3
No clear trend
Williams %R
-73.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-36.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−11.4%
Change over 10 sessions
Bearish
ATR (14)
$2.63
Typical daily range, 6.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 12.4%/day
Key levels
$48.7852 week high+22.2%
$41.8520 day average+4.9%
$41.81100 day average+4.8%
$41.1450 day average+3.1%
$40.97Pivot R1+2.7%
$40.77Swing high (Jun 1)+2.2%
$40.34Pivot+1.1%
$39.91Last close
$39.27Pivot S1−1.6%
$38.51Swing low (Sep 29)−3.5%
$37.34200 day average−6.4%
$19.7652 week low−50.5%
Indicators
RSI (14)
50.65
Middle of its range
Neutral
MACD
1.79
Below its signal line
Bearish
Stochastic
61.3
Middle of its range
Neutral
ADX (14)
39.5
Trending up
Williams %R
-67.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-1.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−10.1%
Change over 10 sessions
Bearish
ATR (14)
$4.95
Typical daily range, 12.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for EWTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how EWTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow EWTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for EWTXHow many large options trades hit EWTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in EWTX in the last 90 days.
From SEC Form 4 filings by EWTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EWTX is in one of them and how their past EWTX trades turned out.
Edgewise Therapeutics is a biopharmaceutical company based in Boulder, Colorado, that develops small molecule medicines for serious muscle diseases. Its main candidates target rare muscular dystrophies, including Duchenne and Becker, and a heart condition called hypertrophic cardiomyopathy. The company uses its own drug discovery platform to find treatments that act on muscle tissue, and these candidates are still in clinical trials. It is developing the therapies for patients with these conditions and the physicians who treat them.